Musculoskeletal
Shoulder Pain
44
Pipeline Programs↗
8
Active Trials↗
24
Companies Involved↗
Shoulder pain is a moderately active landscape with 44 programs across 24 companies. The most active players are Revance Therapeutics, Inc., Hope Pharmaceuticals, Hisamitsu Pharmaceutical Co., Inc.. 27 therapies are approved with 3 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical8
Phase 13
Phase 23
Phase 33
Analysis
Trial Status
54
clinical trials
Completed29 · 54%
Unknown status11 · 20%
Not yet recruiting4 · 7%
Terminated4 · 7%
Recruiting3 · 6%
Withdrawn2 · 4%
Other1 · 2%
Clinical Trials
Trial Activity
54 trials
Effects of Physical Activity and Education Interventions on Neck and Shoulder Pain, Lifestyle Factors, Psychological Factors, and Quality of Life Among Primary School Children in Shijiazhuang, China
Not yet recruiting·—·Preclinical·NCT07661875·100 enrolled
Can Parecoxib Reduce Post-operative Ipsilateral Shoulder Pain?
Completed·—·Phase 2·NCT01288924·160 enrolled
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)